Use of Direct Oral Anticoagulants in Patients with Sickle Cell Disease and Venous Thromboembolism: A Prospective Cohort Study of 12 Patients - Aix-Marseille Université Accéder directement au contenu
Article Dans Une Revue Hemoglobin Année : 2019

Use of Direct Oral Anticoagulants in Patients with Sickle Cell Disease and Venous Thromboembolism: A Prospective Cohort Study of 12 Patients

Fichier non déposé

Dates et versions

hal-02463172 , version 1 (31-01-2020)

Identifiants

Citer

Jacques-Robert Christen, Julien Bertolino, Estelle Jean, Laurence Camoin, Mikael Ebbo, et al.. Use of Direct Oral Anticoagulants in Patients with Sickle Cell Disease and Venous Thromboembolism: A Prospective Cohort Study of 12 Patients. Hemoglobin, 2019, 43 (4-5), pp.296-299. ⟨10.1080/03630269.2019.1689997⟩. ⟨hal-02463172⟩

Collections

SSA CNRS UNIV-AMU
52 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More